Video

Founding 'Faery' Shares Resources and Inspiration Behind Blue Faery Liver Cancer Association

Author(s):

Andrea Wilson
Conference|ASCO Annual Meeting

Andrea Wilson, president and founder of Blue Faery: The Adrienne Wilson Liver Cancer Association, spoke with CURE® at the 2019 ASCO meeting about the loss of her sister and how it inspired her to found Blue Faery.

After realizing no organizations existed for patients with hepatocellular carcinoma (HCC) and their caregivers, Andrea Wilson founded Blue Faery: The Adrienne Wilson Liver Cancer Association to help prevent, treat and cure liver cancer through research, education and advocacy.

Wilson founded Blue Faery about a year and a half after her sister passed away in 2001 — just 147 days with the disease. “I knew the rate of liver cancer was going to rise in this country. I didn’t want anyone else to go through what we did.”

At the 2019 American Society of Clinical Oncology Annual Meeting, Wilson spoke about the loss of her sister and how it inspired her to found Blue Faery, while also sharing, information about the resources available, such as the online forum for patients and caregivers.

Related Videos
Image of Doctor with blonde hair.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Image of man with grey hair.
Image of woman with blonde hair.
Related Content
Illustration of bladder.
February 21st 2025

Neoadjuvant Chemotherapy Plus Chemoradiation Safe, Effective in Bladder Cancer

Roman Fabbricatore
For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was effective in the long term.
cancer horizons image for podcast
December 14th 2023

Conference Highlights from the 2023 ASH Annual Meeting

Brielle Benyon Alex Biese
CURE® recently covered the 2023 American Society of Hematology Annual Meeting. In case you missed it, here is some news that came out of the conference that patients should know about.
Illustration of bladder cancer.
February 20th 2025

Bavencio and BSC Extends Survival in Bladder Cancer, Regardless of Diabetes Status

Jax DiEugenio
Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes mellitus status.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Illusration of liver.
February 19th 2025

SBRT May Be Superior to Radiofrequency Ablation in Liver Cancer

Spencer Feldman
SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.
In patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses. © stock.adobe.com.
February 18th 2025

UGN-102 Shows Complete Response Rates in Low-Grade Bladder Cancer

Ashling Wahner
Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the phase 3 ENVISION and ATLAS studies.